Contact Us

about novelMed

NovelMed is actively seeking investments, partnerships, or acquisition opportunities to advance its pipeline of antibody therapies. Our lead candidates have successfully completed clinical trials in healthy volunteers and are now progressing through Phase II clinical trials for multiple complement-mediated diseases.

Useful links